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Protein–protein recognition, hydride transfer and proton
pumping in the transhydrogenase complex
Patrick A Buckley1, J Baz Jackson2, Thomas Schneider3, Scott A White2,
David W Rice1 and Patrick J Baker1*
Background: Membrane-bound ion pumps are involved in metabolic regulation,
osmoregulation, cell signalling, nerve transmission and energy transduction.
How the ion electrochemical gradient interacts with the scalar chemistry and
how the catalytic machinery is gated to ensure high coupling efficiency are
fundamental to the mechanism of action of such pumps. Transhydrogenase is a
conformationally coupled proton pump linking a proton gradient to the redox
reaction between NAD(H) and NADP(H). The enzyme has three components;
dI binds NAD(H), dII spans the membrane and dIII binds NADP(H). 
Results: The first crystal structure of a transhydrogenase dI component (from
Rhodospirillum rubrum) has been determined at 2.0 Å resolution. The monomer
comprises two domains. Both are involved in dimer formation, and one has a
Rossmann fold that binds NAD+ in a novel mode. The two domains can adopt
different conformations. In the most closed conformation, the nicotinamide ring
is expelled from the cleft between the two domains and is exposed on the
outside of the protein. In this conformation it is possible to dock the structure of
dI/NAD+ with that of a dIII/NADP+ complex to provide the first insights into the
molecular basis of the hydride-transfer step.
Conclusions: Analysis of the model of the dI/dIII complex identifies residues
potentially involved in dI/dIII interaction and shows how domain motion in dI
results in a shift in position of the nicotinamide ring of NAD+. We propose that
this movement is responsible for switching between the forbidden and allowed
states for hydride transfer during proton pumping.
Introduction 
Ion pumps have diverse and important functions in biologi-
cal membranes. They are involved in metabolic regulation,
osmoregulation, cell signalling, nerve transmission and
energy transduction. Studies of some ion pumps, which
operate through the interplay of the protein with its pros-
thetic groups [1–3], are developing apace but information
on the conformationally coupled pumps, such as the ion-
transporting ATPases, is more difficult to obtain. Despite
the emergence of new structures for these proteins [4–6],
the identification of reaction intermediates has been prob-
lematic. In the living cell, the pools of NAD(H) and
NADP(H) are maintained at different redox potentials, to
allow independent control of catabolism and biosynthesis.
NAD+ is the predominant electron acceptor in catabolism,
whereas the major supplier of reducing power in biosyn-
thesis is NADPH. Transhydrogenase is a conformationally
coupled proton pump that links the redox reaction
between NAD(H) and NADP(H) to a proton gradient (see
equation 1) [7]. It is a good model system for understand-
ing the properties of this important class of molecules.
NADH + NADP+ + H+out ↔ NAD+ + NADPH + H+in   (1)
The enzyme is well suited to kinetic studies as the trans-
fer of hydride equivalents between NAD(H) and
NADP(H) is direct and does not involve redox intermedi-
ates [8]. The protein is distributed widely in the cytoplas-
mic membranes of bacteria and the inner membranes of
animal mitochondria. Under most physiological conditions
the reaction is driven in the direction of NADPH synthe-
sis by the proton gradient generated by respiratory (or
photosynthetic) electron transport. Transhydrogenase has
three components, dI, dII and dIII, which are located,
depending upon species, on one, two or three polypep-
tides; dI has the binding site for NAD(H), dIII for
NADP(H), and dII spans the membrane. Recently, the
structures of the dIII components of bovine [9], human
[7,10] and Rhodospirillum rubrum [11] transhydrogenases
were reported. Although dIII appears to have a classical
Rossmann fold [12], its bound NADP+ is in a reverse ori-
entation, with the nicotinamide ring exposed on a ‘ridge’.
Here, we describe the first crystal structure of a trans-
hydrogenase dI component, that from the R. rubrum
enzyme, in its NAD+ form. The structure reveals a novel
mode of NAD+ binding, the residues involved in dI/dIII
recognition, and those critical for hydride transfer. It also
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suggests that unique features are involved in the coupling
of hydride transfer to proton pumping.
Results and discussion
dI Architecture and topology
In the crystal structure, the isolated dI component folds
into two domains; dI.1 (residues 1–137 and 328–384), and
dI.2 (residues 138–327), which bear a marked resemblance
to each other and which are separated by a deep cleft.
Each domain is an open, twisted, mainly parallel, β sheet
flanked by α helices, and each has the appearance and
connectivity of the Rossmann fold [12]. The C termini of
the cores of the two sheets face towards each other across
the cleft, and the domains are linked by two long α helices
(Figure 1). Within each polypeptide subunit, there is a
total of 13 α helices, 17 β strands and 6 stretches of chain
in 310-helical conformation that account for 31.5%, 17.6%
and 5.2% of the residues, respectively. Together with
hydrogen-bonded turns, 72.3% of the chain adopts a
regular secondary structure, and 63.4% of all possible
mainchain hydrogen bonds are made.
Both the fold and sequence of the dI component of the
membrane-bound transhydrogenase are strikingly similar
to that of the soluble hexameric alanine dehydrogenase
(AlaDH) [13], reflecting an evolutionary relationship
between them. There is considerable pair-wise sequence
similarity between these two protein families with, for
example, 27% sequence identity between the dI compo-
nent from R. rubrum transhydrogenase and the AlaDH
from Phormidium lapideum. Furthermore, 42 residues are
strongly conserved (defined as identical in at least 9 out of
the 11 published sequences available for each of AlaDH
and dI). The polypeptide connectivities of dI and AlaDH
are very similar, with differences mainly confined to loops
between strands and helices. Between the 157 equivalent
α carbon atoms of dI.1 of R. rubrum transhydrogenase, and
domain 1 of P. lapideum AlaDH, and between the 147
equivalent α carbon atoms of dI.2, and domain 2 of
AlaDH, the root mean square (rms) deviations are only
1.36 and 1.44 Å, respectively.
There are four subunits, designated A–D, in the asymmet-
ric unit of the dI crystals. Relative to subunit A, the rms
deviations for the α carbons of subunits B, C and D are
0.54, 0.59 and 0.34 Å, respectively, for dI.1, and 0.32, 0.35
and 0.41 Å, respectively, for dI.2. The four subunits
assemble into two dimers (A/C and B/D). The contact
regions between the two subunits in the dimer are similar
to those seen across the twofold axis in AlaDH. Residues
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Structure
The dI component of transhydrogenase. (a) A stereo representation of
the Cα backbone of a single subunit. (b) A cartoon of the dI dimer,
viewed down the twofold axis, showing the NAD+ (magenta ball and
sticks) bound to each subunit. (c) The final (2Fo–Fc) electron density
map, contoured at 0.7 σ, around the NAD+ bound to the most closed
subunit D.
at the C-terminal ends of helices 136–155 and 182–193
from domain dI.2 pack against their twofold-related part-
ners. The extended β loop (residues 156–172) from dI.2
packs against residues from both domains of the twofold-
related subunit (residues 132–150 and 326–337), and
residues 43–44 from dI.1 pack against residues 286–287
from dI.2 of the twofold-related subunit. These contacts
are probably responsible for the dimeric structure of iso-
lated dI observed in solution [14]. In the crystal, the two
dimers pack together with only limited interactions
between them, in an arrangement that forms a 222
tetramer. As there is no biochemical evidence to indicate
that transhydrogenase forms a tetramer in solution, this
might be an artefact of the crystal packing.
In both dI and AlaDH, NAD+ binds in a crevice at the
C-terminal ends of the central β strands of the second
domain (dI.2). However, whereas the adenine, the
adenine-ribose and the pyrophosphate moieties of the
NAD+ occupy similar positions in both enzymes, the
nicotinamide ring and its associated ribose occupy a com-
pletely different orientation in dI to that seen in AlaDH,
and in most other NAD(P)+-binding enzymes containing
the Rossmann fold. Thus, the nicotinamide ring, rather
than lying deep in the interdomain cleft, is positioned on
the outside of dI.2 (Figure 2). Relative to AlaDH there is
an ~20 residue insert in the NAD+-binding domain of dI
(residues 221–240). Nuclear magnetic resonance (NMR)
experiments have indicated that this segment is mobile,
and that flexibility is restricted when dI binds NAD(H)
[15]. The crystal structure shows that the 221–240 loop
extends into the interdomain cleft of each subunit, and
interacts with the bound NAD+.
Domain movement and NAD+ conformation
The two domains, dI.1 and dI.2, are held in open (subunits
B and C), intermediate (subunit A) or closed conformations
(subunit D). There are two hinge regions between dI.1 and
dI.2. One is located around residues 135–137, at the N ter-
minus of the helix that leads from dI.1 into dI.2; the other
is positioned between residues 326–328, at the N-terminal
end of the helix leading from dI.2 back into dI.1. Displace-
ments around these two hinges effectively result in a rigid
body movement of one domain relative to the other in each
subunit. In the most open subunits (B and C), the electron
density for the nicotinamide rings of the respective NAD+
molecules is very weak, presumably indicating some
degree of disorder. In the intermediate state (subunit A), in
which the two domains lie closer together, the density for
the nicotinamide ring is well defined. The ring adopts a syn
conformation with respect to its ribose moiety, and the car-
boxyamide makes hydrogen bonds both with the
pyrophosphate group, and with the sidechains of the
invariant residues Tyr235 and Asp135 (Figure 3a). As the
sides of the cleft in dI close further (subunit D), the two
domains and the NAD+ pack tightly against each other and
the nicotinamide ring cannot adopt the position it occupies
in subunit A. The ring, and its associated ribose, are
expelled from the interdomain cleft, and rotation about the
glycosidic bond of the nicotinamide ribose generates the
anti conformer (Figure 3b). The guanidinium group of
invariant Arg127 (disordered in subunit A) takes up a posi-
tion similar to that of the nicotinamide carboxyamide in
the intermediate state, making interactions with the
pyrophosphate and with the sidechains of Tyr235 and
Asp135. The pro-S face of the nicotinamide ring makes
contacts with the residues from dI.1 across the cleft (to the
mainchain of residues 127–129, and the sidechain of invari-
ant Gln132), and thus presents its pro-R face to the solvent.
The dI/dIII complex
In solution, the isolated dI and dIII components of trans-
hydrogenase (from the same or even different species)
readily form a complex, which catalyses the rapid and direct
transfer of hydride equivalents between NAD(H) and
NADP(H) [8]. We have investigated the dI/dIII interaction
by docking the static surfaces of R. rubrum dI (subunit D)
and human dIII, as provided by the two X-ray structures.
Although there are uncertainties in this approach, for
example associated with conformational changes taking
place during binding, the two surfaces can be docked such
that the pro-R face of the nicotinamide ring of the NAD+ on
dI is brought into apposition with that of the pro-S face of
the NADP+ on dIII, at a separation of ~3.0 Å between the
C4 atoms (Figure 4). This is in accordance with the rapid
rate of hydride transfer, and it satisfies the known C4-pro-
R/C4-pro-S stereochemistry of the reaction [16], thus 
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Figure 2
A comparison of the mode of NAD+ binding to dI.2 of transhydrogenase
(blue protein /magenta NAD+) with that to domain 2 of alanine
dehydrogenase (green/yellow). The flexible loop in dI (residues
221–240) which orders on NAD+ binding is red. 
providing considerable confidence for the proposed organi-
sation. The few steric clashes that occur between the
sidechains of the two polypeptides can be relieved by only
very small adjustments to the individual structures. Within
the modelled complex, the ridge of dIII [7,10] docks into
the side of the cleft of dI, making contacts with both dI.1
and dI.2. Many of the interfacial residues are conserved
(that is, they are identical in 9 out of 11 published
sequences). Amongst the conserved residues involved in
this interaction are Ala131 and Gln132, from the 127–132
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Figure 3
(a) Close up of the nicotinamide-binding site
in the intermediate state (subunit A) of dI,
showing the carboxyamide interacting with the
pyrophosphate and the invariant residues
Tyr235 and Asp135. (b) In the closed state of
dI (subunit D), the nicotinamide swings round
to adopt the anti conformer, and packs against
Gln132. In this subunit Arg127 is ordered and
interacts with Tyr235 and Asp135.
Figure 4
(a,b) Views of the docked structures of the D
subunit dI (blue) and dIII (gold) components
of transhydrogenase. The C4 of the
nicotinamide ring of the dI NAD+ (magenta) is
~3.0 Å from its counterpart on the NADP+
bound to dIII (green). The sidechains of
residues identical, or strongly conserved, in
the dI and dIII components from different
species are coloured red and yellow,
respectively. Residues from the twofold-
related subunit of dI, which impinge on the
hydride transfer site, can be seen coloured
cyan (conserved residues in grey). 
loop of dI.1, and Val182, Leu185, Arg204, Glu209, Gln210
and Ser213 from the α helices that are part of the N-termi-
nal portion of dI.2. In addition, the conserved residues
Thr165, Ala166, Ala167 and Gly168 from the 156–172 loop
of dI.2 from the twofold-related subunit in the dI dimer are
also involved in the interface. In dIII, the surfaces either
side of the nicotinamide-binding ridge (including the con-
served residues His920, Pro921, Val922, Ala923, Gly924,
Arg925, Pro927, Gly928, Met984, Pro985, Arg1000, Gly1005
and Tyr1006; human dIII numbering) pack against dI in
the proposed dI/dIII complex. The model is supported by
the observation that resonances of all 12 backbone amide
groups in 15N-labelled dIII, which are in intermediate
exchange after addition of unlabelled dI [17], are assigned
to residues that locate within these interfacial regions. It is
interesting to note that, in the model of the dI/dIII
complex, the sidechain hydroxyl of invariant Tyr1006 from
dIII is within hydrogen bonding distance of the 2′ and 3′
hydroxyls of the nicotinamide ribose from the NAD+ bound
to dI. All four dI subunits can dock with dIII in an equiva-
lent manner, but only in the complex with the closed con-
formation (subunit D) are the nicotinamide rings close
enough for redox chemistry. For example, in the intermedi-
ate state (subunit A), the C4 atom of the nicotinamide ring
of NAD+ is 4.5 Å from that of the docked dIII.NADP+.
The gating of hydride transfer
In the complete enzyme, the proton-binding and proton-
release steps of ion translocation across the membrane are
associated with changes in the mode of binding of NADP+
and NADPH [7]. Conformational changes are required to
switch between a state in which hydride transfer is forbid-
den, and a state in which it is allowed. A failure in this
device would lead to the scalar chemical reaction proceed-
ing without proton translocation. The absence of redox
intermediates indicates that the switch must result from
relative movement of the two nicotinamide rings; the rate
of hydride transfer will decrease with separation of the C4
atoms. Cleft closure in the dI component, and its atten-
dant changes in hydrogen-bonding, result in a shift in
position of the nicotinamide ring of NAD+, and we
propose that this movement is responsible for switching
between the forbidden and allowed states for hydride
transfer during proton pumping. Supporting evidence for
this mechanism is provided from mutagenesis studies,
which previously indicated that Tyr235 has little effect on
either the NAD(H) binding affinity or the interaction
between dI and dIII, but is crucial in the hydride-transfer
step [18]. During catalysis, the switch is coordinated with
changes in the binding affinity of dIII for NADP(H). We
suggest that the coordination is mediated, at least partly,
through the conformational changes of the dI 127–132
loop indicated above. This short segment is in contact
with elements of the dIII protein, all of which have a pre-
dominance of invariant or highly conserved residues,
including the buried carboxylate of Asp967 of dIII, whose
ionisation state is thought to be central to changes in the
binding of NADP(H) [7,10].
There is strong biochemical evidence that the dIII com-
ponent of transhydrogenase is in contact with the mem-
brane-spanning dII [19], but to our knowledge there is
none to suggest that dI is in contact with dII. The
docked structure, described above, reveals that the
active site of the dI/dIII complex contains elements
from both a dI monomer and from its twofold-related
partner in the dimer. This strongly supports the view
that the complete transhydrogenase is a dimer in the
membrane. In the model, two dIII subunits are located
on the same face of the dI dimer, as dictated by the rela-
tive positions of the NAD+-binding sites with respect to
the twofold axis of the dimer. Similarly, the position of
the twofold axis restricts the relative position of dI/dIII
with respect to the membrane and determines that the
membrane, and its associated dII components, must lie
perpendicular to this axis. Of the two possible locations
for the plane of the membrane, either adjacent to dI or
to dIII, only the latter is consistent with the biochemical
data. This places the dI component some 25 Å from the
membrane surface (Figure 5).
The crystal structure of the transhydrogenase dI compo-
nent, together with that of dIII, shows for the first time how
these two polypeptides might be associated in the intact
complex, and it yields a plausible mechanism to explain the
gating of the scalar hydride-transfer reaction, which ensures
tight coupling with transmembrane protontranslocation.
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Figure 5
A schematic representation of the possible orientation of the
transhydrogenase complex with respect to the membrane. The dI
dimer (blue/cyan) and its two associated dIII components (gold) lie
above the membrane (green lipids, red head groups) with the two dII
components (blue ovals) interacting with the dIII components.
Biological implications
Ion pumps have diverse and important functions in bio-
logical membranes. The central problems in understand-
ing the mechanism of action of an ion pump are: firstly, to
characterise power strokes in which the ion electrochemi-
cal gradient interacts with scalar chemistry; and secondly,
to establish how the catalytic machinery is gated to ensure
high coupling efficiency. Transhydrogenase is a confor-
mationally coupled proton pump that links a proton gradi-
ent to the redox reaction between NAD(H) and
NADP(H) and is a good model system for understanding
the properties of this important class of molecules.
We describe here the first structure of the NAD(H)-
binding, dI component of transhydrogenase. It is from
the Rhodospirillum rubrum enzyme and is in complex
with NAD+. The protein is a dimer, with each subunit
comprising two domains separated by a cleft. The struc-
ture and sequence of the dI component of transhydroge-
nase bear a marked similarity to alanine dehydrogenase
(AlaDH). However, NAD+ binds to the dI component in
a different manner to that seen in AlaDH and most
other Rossmann fold–dinucleotide-binding proteins.
Although the adenine, adenine ribose and pyrophosphate
moieties of the NAD+ in dI occupy similar positions to
those seen in AlaDH, the nicotinamide ring and its asso-
ciated ribose are curved away from the cleft, with the
nicotinamide ring on the outside of the domain. Based on
the position of the NAD+ bound to dI, and with the
knowledge that the hydride transfer between NAD(H)
on dI and NADP(H) on dIII is direct, the dIII compo-
nent of transhydrogenase can be docked onto the dI
structure to form a model of the dI/dIII complex, with
many of the interfacial residues conserved in the
sequences of transhydrogenase. Furthermore, structural
analysis of the dI component of transhydrogenase shows
that the two domains can adopt different relative confor-
mations with respect to each other. This domain move-
ment has the effect of displacing the nicotinamide ring of
the NAD+ on dI away from that of the NADP(H) on
dIII. We propose that this movement is responsible for
switching between the forbidden and allowed states for
hydride transfer during proton pumping.
Materials and methods
Crystallization and data collection
Selenomethionine (SeMet) labelled R. rubrum dI was purified and crys-
tals grown as described previously [20]. The crystals are in space
group P21, with cell dimensions a = 65.9 Å, b = 116.6 Å, c = 102.0 Å
and β = 104.2°, and have four polypeptide chains in the asymmetric
unit with a Matthew’s volume, Vm = 2.36 Å3/Da. Although the dI
protein crystallises readily, virtually all crystals were either disordered in
one direction or showed poor diffraction. Over 60 SeMet dI crystals
were stabilised in 15% PEG400, 10 mM NAD+, 25% methyl ethyl
PEG2000, 200 mM sodium phosphate buffer, pH 7.5 and 30 mM
ammonium sulphate, prior to flash freezing at 100K. Test images taken
on a rotating anode/image plate system showed that only one of these
crystals gave high resolution and ordered diffraction, and this crystal
was transported to the ESRF synchrotron. Data were collected to
2.0 Å on BM 30 at three wavelengths (0.9796 Å, 0.9794 Å and
0.9686 Å) corresponding to the Se K-edge f′ minimum, f′′ maximum
and high energy distant positions, as determined from a fluorescence
scan of the crystal. The data were processed and merged using
DENZO/SCALEPACK [21] (Table 1). 
Structure determination
The diffraction data were analysed and FA values determined using a
developmental version of the program XPREP (Bruker AXS, Madison,
USA). The anomalous signal was found to extend to 2.5 Å and FA
values were truncated to this resolution. The SeMet substructure was
solved using the ‘half-baked’ approach as implemented in the program
SHELXC [22]. Fifty-two sites were found and validated, based on con-
sistency with the Patterson function and with the noncrystallographic
symmetry, by manual inspection of the crossword table provided by
SHELXC. Diffraction data were manipulated with the CCP4 suite of
programs [23]. The Se sites were refined and phases calculated using
MLPHARE using the λ3 data as native. Solvent flattening was applied
using DM and an initial model was built into the multiwavelength anom-
alous diffraction phased map at 2.5 Å, using TURBO-FRODO [24].
Rounds of refinement and rebuilding, with automatic solvent addition
using REFMAC/ARP resulted in a final model of 12741 atoms, includ-
ing 1459 solvent, with R = 0.21 and Rfree = 0.26 (Table 2). The overall
average B is 29.3 Å2 and 32.1 Å2 for the protein mainchain and
sidechain atoms, respectively. The electron density was weak for the
nicotinamide rings of NAD+ bound to subunits B and C and for
residues 226–227A, 350–352B, 350–351C, 378–384C, 349–351D
and 381–384D, all of which have been omitted from the final model. A
number of loops in the structure have high temperature factors
(228A–245A, 348A–355A, 220B–253B, 347B–353B, 380B–384B,
220C–250C, 347C–355C, 375C–378C, 220D–250D, 345D–362D
and 375D–380D) and the sidechains of a number of surface residues
also have weak electron density, which is mirrored in their high temper-
ature factors. In the final model there are no nonglycine Ramachandran
outliers, 92.6% of the residues are in the most favoured conformation
and 51 of the initial 52 Se sites corresponded to actual SeMet posi-
tions. All figures in this paper have been prepared using TURBO-
FRODO [24], Midas [25] and Molscript [26].
Modelling the dI/dIII complex
To construct the model of the dI/dIII complex the nicotinamide ring of
the NADP+ bound to human dIII (PDB code 1DJL) was placed next to
the nicotinamide ring of the NAD+ bound to dI, such that the C4 atoms
of the respective nicotinamide rings were 2.9 Å apart. The dIII/NADP
complex coordinates were then rotated about the C4 atom to see if
there was any orientation in which the atoms of dI and dIII did not
clash. It was immediately apparent that there was only one orientation
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Table 1
Data collection and phasing.
Data set λ1 (0.9796) λ2 (0.9794) λ3 (0.9686)
dmin (Å) 2.0 2.0 2.0
No. of unique 93,731 93,853 99,140
reflections
Completeness (%) 87.5 87.7 94.7
Redundancy 2.80 2.87 3.22
I/σI 13.38 (2.24) 12.86 (2.06) 14.06 (2.50)
Rsym (%)† 4.4 (27.1) 4.7 (29.5) 4.3 (27.1)
Data collection statistics for the MAD SetMet data. Where appropriate,
the values in parentheses, are for data in the highest resolution shell.
†Rsym = Σj|<I>–Ij|/Σ<I>, where Ij is the intensity of the jth reflection and
<I> is the average intensity.
(where the two nicotinamide rings were approximately parallel to each
other) in which the two protein surfaces packed against each other and
there were no major clashes between the atoms of the two compo-
nents. In this model there are a small number of minor sidechain
clashes, which could be alleviated by small rotations of the offending
sidechains. In the real biological complex it is probable that there will
be a number of small adjustments to the positions of the interfacial
residues, to maximise the binding potential between the two compo-
nents. These are difficult to predict, and we have therefore not altered
the conformation of any residues in our modelled complex.
Accession numbers
The atomic coordinates for transhydrogenase dI have been deposited
in the Protein Data Bank with accession number IF8G.
Acknowledgements
We thank Michel Roth of the ESRF, Grenoble, France for station alignment
and help in data collection, and the BBSRC, The New Energy and Industrial
Development Organization, The Wellcome Trust and the British Council/
The Royal Society Anglo-Japanese Scientific Exchange Scheme for financial
support. The Krebs Institute is a BBSRC funded molecular recognition
centre and a member of the North of England Structural Biology Centre.
References
1. Luecke, H., Schobert, B., Richter, H.T., Cartailler, J.P. & Lanyi, J.K.
(1999). Structural changes in bacteriorhodopsin during ion transport
at 2 Angstrom resolution. Science 286, 255-260.
2. Crofts, A.R., Hong, S.J., Ugulava, N., Barquera, B., Gennis, R.,
Guergovakuras, M. & Berr, E.A. (1999). Pathways for proton release
during ubihydroquinone oxidation by the cytochrome bc(1) complex.
Proc. Natl. Acad. Sci. USA 96, 10021-10026.
3. Michel, H. (1999). Bioenergetics — proton pumping by cytochrome 
c oxidase. Nature 402, 602-603.
4. Abrahams, J.P., Leslie, A.G.W., Lutter, R. & Walker, J.E. (1994).
Structure at 2.8 Å resolution of F1-ATPase from bovine heart
mitochondria. Nature 370, 621-628.
5. Stock, D., Leslie, A.G.W & Walker, J.E. (1999). Molecular architecture
of the rotary motor in ATP synthase. Science 286, 1700-1705.
6. Kuhlbrandt, W., Auer, M. & Scarborough, G.A. (1998). Structure of
P-type ATPases. Curr. Opin Struct. Biol. 8, 510-516.
7. Jackson, J.B., Peake, S.J. & White, S.A. (1999). Structure and
mechanism of proton-translocating transhydrogenase. FEBS Lett.
464, 1-8.
8. Venning, J.D., Grimley, R.L., Bizouarn, T., Cotton, N.P.J. & Jackson, J.B.
(1997). Evidence that the transfer of hydride equivalents between
nucleotides by proton-translocating transhydrogenase is direct. J. Biol.
Chem. 272, 27535-27538.
9. Prasad, G.S., Sridhar, V., Yamaguchi, M., Hatefi, Y. & Stout, C.D.
(1999). Crystal structure of transhydrogenase domain III at 1.2 Å
resolution. Nat. Struct. Biol. 6, 1126-1131.
10. White, S.A., Peake, S.J., McSweeney, S., Leonard, G., Cotton, N.P.J. 
& Jackson, J.B. (2000). The high resolution structure of the NADP(H)-
binding component of proton-translocating transhydrogenase from
human-heart mitochondria. Structure 8, 1-12.
11. Jeeves, M., Smith, K.J., Quirk, P.G., Cotton, N.P.J. & Jackson, J.B.
(2000). Solution structure of the NADP(H)-binding component (dIII) 
of proton-translocating transhydrogenase from Rhodospirillum
rubrum. Biochim. Biophys. Acta, in press.
12. Rossmann, M.G., Moras, D. & Olsen, K.W. (1974). Chemical and
biological evolution of a nucleotide-binding protein. Nature
250, 194-199.
13. Baker, P.J., Sawa, Y., Shibata, H., Sedelnikova, S.E. & Rice, D.W.
(1998). The structure of alanine dehydrogenase; convergent and
divergent evolution in action. Nature Struct. Biol. 5, 561-567.
14. Diggle, C., Hutton, M., Jones, G.R., Thomas, C.M. & Jackson, J.B.
(1995). Properties of the soluble polypeptide of the proton-
translocating transhydrogenase from Rhodospirillum rubrum obtained
by expression in Escherichia coli. Eur. J. Biochem. 228, 719-726.
15. Quirk, P.G., Smith, K.J., Thomas, C.M. & Jackson, J.B. (1999). The
mobile loop region of the NAD(H)-binding component (dI) of proton-
translocating transhydrogenase from Rhodospirillum rubrum:
complete NMR assignment and effects of bound nucleotides.
Biochim. Biophys. Acta 1412, 139-148.
16. Lee, C.P., Simard-Duquesne, N., Ernster, L. & Hoberman, H.D. (1965).
Stereochemistry of hydrogen transfer in the energy-linked pyridine
nucleotide transhydrogenase and related reactions. Biochim. Biophys.
Acta 105, 397-409.
17. Quirk, P.G., Jeeves, M., Cotton, N.P.J., Smith, K.J. & Jackson, J.B.
(1999). Structural changes in the recombinant, NADP(H)-binding
component (dIII) of proton-translocating transhydrogenase revealed by
NMR spectroscopy. FEBS Lett. 446, 127-132.
18. Bizouarn, T., Grimley, R.L., Diggle, C., Thomas, C.M. & Jackson, J.B.
(1997). Mutations at Tyrosine-235 in the mobile loop region of domain I
protein of transhydrogenase from Rhodospirillum rubrum strongly inhibit
hydride transfer. Biochim. Biophys. Acta 1320, 265-274.
19. Cunningham, I.J., Williams, R., Palmer, T., Thomas, C.M. &
Jackson, J.B. (1992). The relation between the soluble factor
associated with H+-transhydrogenase of Rhodospirillum rubrum and
the enzyme from mitochondria and Escherichia coli. Biochim.
Biophys. Acta 1100, 332-338.
20. Sedelnikova, S.E., et al., & Baker, P.J. (2000). The crystallization of the
dI component of transhydrogenase, a proton-translocating membrane
protein. Acta Crystallogr. D, in press.
21. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction
data collected in oscillation mode. Methods Enzymol. 276, 307-326.
22. Sheldrick, G.M. (1998). SHELX: applications to macromolecules. In
Direct Methods for Solving Macromolecular Structures. (Fortier,S. ed)
pp. 401-411, Kluwer Academic Publishers, Dordrecht.
23. Collaborative Computing Project no.4 (1994). The CCP4 suite:
Programs for Protein Crystallography. Acta Crystallogr. D 50, 760-763 
24. Roussel, A. & Cambillau, C. (1991). Silicon Graphics Geometry
Partners Directory 86. Silicon Graphics, Mountain View, CA.
25. Ferrin, T.E., Huang, C.C., Jarvis, L.E. and Langridge, R. (1988). The
MIDAS display system. J. Mol. Graph. 6, 13-27.
26. Kraulis, P.J. (1991). Molscript — a program to produce both detailed and
schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.
Research Article  The transhydrogenase complex Buckley et al. 815
Table 2
Refinement.
Reflections 90649
Non-H atoms 12741
R factor* 0.21
Rfree† 0.26
Rms distance deviations‡ (Å)
Bonds 0.007
Angles 0.025
Rms delta B (Å2)
Mainchain 0.78
Sidechain 0.97
Average B (Å2)
Mainchain 29.3
Sidechain 31.1
*R factor = Σhkl | | Fo | – | Fc | | /Σhkl | Fo |. †Rfree is the crystallographic R
value calculated using 5% of the native data withheld from refinement.
‡Root mean square (rms) bond lengths and angle distances are the rms
deviations from ideal bond lengths and angle distances, respectively.
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